Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Amoxicillin 500mg capsules
0501013B0AAABAB
|
Amoxicillin | Amoxicillin | Infections | 784,063 |
|
Amoxicillin 250mg/5ml oral suspension sugar free
0501013B0AAATAT
|
Amoxicillin | Amoxicillin | Infections | 259,094 |
|
Amoxicillin 250mg/5ml oral suspension
0501013B0AAAKAK
|
Amoxicillin | Amoxicillin | Infections | 110,917 |
|
Amoxicillin 125mg/5ml oral suspension sugar free
0501013B0AAASAS
|
Amoxicillin | Amoxicillin | Infections | 63,949 |
|
Amoxicillin 125mg/5ml oral suspension
0501013B0AAAJAJ
|
Amoxicillin | Amoxicillin | Infections | 27,883 |
|
Amoxicillin 250mg capsules
0501013B0AAAAAA
|
Amoxicillin | Amoxicillin | Infections | 22,819 |
|
Amoxicillin 500mg/5ml oral suspension sugar free
0501013B0AAAVAV
|
Amoxicillin | Amoxicillin | Infections | 6,309 |
|
Amoxicillin 3g oral powder sachets sugar free
0501013B0AAAHAH
|
Amoxicillin | Amoxicillin | Infections | 1,154 |
|
Amoxil 500mg capsules
0501013B0BCABAB
|
Amoxil (Systemic) | Amoxicillin | Infections | 72 |
|
Amoxicillin 500mg tablets
0501013B0AABDBD
|
Amoxicillin | Amoxicillin | Infections | 57 |
|
Amoxicillin 125mg/1.25ml oral suspension paediatric
0501013B0AAAIAI
|
Amoxicillin | Amoxicillin | Infections | 29 |
|
Amoxicillin 1g dispersible tablets sugar free
0501013B0AAAUAU
|
Amoxicillin | Amoxicillin | Infections | 18 |
|
Amoxil 125mg/1.25ml paediatric oral suspension
0501013B0BCAGAI
|
Amoxil (Systemic) | Amoxicillin | Infections | 1 |
|
Almodan 125mg/5ml syrup
0501013B0BDABAJ
|
Almodan | Amoxicillin | Infections | No data available |
|
Amix 125 oral suspension
0501013B0BFAGAS
|
Amix | Amoxicillin | Infections | No data available |
|
Amix 250 capsules
0501013B0BFAEAA
|
Amix | Amoxicillin | Infections | No data available |
|
Amix 250 oral suspension
0501013B0BFAIAT
|
Amix | Amoxicillin | Infections | No data available |
|
Amix 500 capsules
0501013B0BFAFAB
|
Amix | Amoxicillin | Infections | No data available |
|
Amoram 125mg/5ml oral suspension
0501013B0BGACAS
|
Amoram | Amoxicillin | Infections | No data available |
|
Amoram 250mg capsules
0501013B0BGAAAA
|
Amoram | Amoxicillin | Infections | No data available |
|
Amoram 250mg/5ml oral suspension
0501013B0BGADAT
|
Amoram | Amoxicillin | Infections | No data available |
|
Amoram 500mg capsules
0501013B0BGABAB
|
Amoram | Amoxicillin | Infections | No data available |
|
Amoxident 250 capsules
0501013B0BRAAAA
|
Amoxident | Amoxicillin | Infections | No data available |
|
Amoxident 500 capsules
0501013B0BRABAB
|
Amoxident | Amoxicillin | Infections | No data available |
|
Amoxil 125mg/5ml syrup sucrose free
0501013B0BCAEAS
|
Amoxil (Systemic) | Amoxicillin | Infections | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.